Covestor’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52K Buy
218
+6
+3% +$1.25K 0.03% 764
2026
Q1
$45K Sell
212
-49
-19% -$10.6K 0.03% 769
2025
Q4
$53K Buy
261
+41
+19% +$7.72K 0.03% 889
2025
Q3
$35K Sell
220
-2
-0.9% -$309 0.02% 1057
2025
Q2
$37K Sell
222
-70
-24% -$10.4K 0.02% 1015
2025
Q1
$40K Sell
292
-100
-26% -$12.7K 0.03% 928
2024
Q4
$47K Sell
392
-42
-10% -$4.9K 0.03% 872
2024
Q3
$48K Sell
434
-3
-0.7% -$314 0.03% 891
2024
Q2
$43K Sell
437
-6
-1% -$611 0.03% 922
2024
Q1
$50K Buy
443
+170
+62% +$18.3K 0.03% 877
2023
Q4
$28K Buy
273
+18
+7% +$1.79K 0.02% 1065
2023
Q3
$22K Sell
255
-39
-13% -$3.53K 0.02% 1073
2023
Q2
$28K Buy
294
+110
+60% +$9.29K 0.02% 996
2023
Q1
$14K Buy
184
+3
+2% +$226 0.01% 1138
2022
Q4
$14K Sell
181
-62
-26% -$4.71K 0.01% 1156
2022
Q3
$16K Sell
243
-3
-1% -$190 0.01% 1061
2022
Q2
$13K Sell
246
-2,756
-92% -$157K 0.01% 1102
2022
Q1
$170K Buy
3,002
+676
+29% +$36.2K 0.11% 212
2021
Q4
$120K Buy
+2,326
New +$114K 0.17% 97

Other funds holding CAH

Covestor's CAH Position: Q2 2026 in Review

Covestor increased its Cardinal Health (CAH) stake by 2.8% in Q2 2026, buying an estimated $1.25K and bringing the position to 218 shares worth $52K. The position accounts for 0.03% of the portfolio, ranked #764.

Covestor first reported a position in CAH in Q4 2021 and has held it in 19 quarters since. The position peaked at $170K in Q1 2022. 1,010 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Covestor held 218 shares of Cardinal Health worth $52K as of Q2 2026.
  • Covestor bought 6 Cardinal Health shares in Q2 2026, an estimated $1.25K.
  • Cardinal Health made up 0.03% of Covestor's portfolio in Q2 2026, its #764 holding.
  • Covestor first reported a position in Cardinal Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Cardinal Health position peaked at $170K in Q1 2022.
  • 1,010 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.